World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
87
Citations
32984
World Ranking
13518
National Ranking
1259

Graham R. Foster publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Graham R. Foster sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 626 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Graham R. Foster D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Graham R. Foster sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 87 D-Index — 34th percentile

34% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Graham R. Foster is affiliated with Queen Mary University of London in the United Kingdom. Their research primarily spans the field of Medicine, with significant contributions in the subfields of Epidemiology, Hepatology, Genetics, General Health Professions, and Infectious Diseases.

The scientist's work focuses extensively on viral hepatitis and liver-related diseases, with notable emphasis on Hepatitis C virus research, Liver Disease Diagnosis and Treatment, Hepatitis B Virus Studies, Liver Disease and Transplantation, Virus-based gene therapy research, Hepatitis Viruses Studies and Epidemiology, and Hemophilia Treatment and Research.

Frequent co-authors collaborating with Graham R. Foster include:

  • Beatrice Emmanouil
  • Saeed Hamid
  • Peter Vickerman
  • Mark Gillyon-Powell
  • Kosh Agarwal

The scientist has published prolifically in several journals, with the most frequent venues being:

  • Journal of Hepatology
  • Journal of Viral Hepatitis
  • bioRxiv (Cold Spring Harbor Laboratory)
  • Journal of Thrombosis and Haemostasis
  • Abstracts

Among the notable recent papers are:

  • "Estimated impact of the COVID-19 pandemic on cancer services and excess 1-year mortality in people with cancer and multimorbidity: near real-time data on cancer care, cancer deaths and a population-based cohort study," 2020, BMJ Open
  • "Estimating excess mortality in people with cancer and multimorbidity in the COVID-19 emergency," 2020, bioRxiv (Cold Spring Harbor Laboratory)
  • "Adjusted estimate of the prevalence of hepatitis delta virus in 25 countries and territories," 2023, Journal of Hepatology
  • "Increased burden of cardiovascular disease in people with liver disease: unequal geographical variations, risk factors and excess years of life lost," 2022, Journal of Translational Medicine
  • "Hepatitis D double reflex testing of all hepatitis B carriers in low-HBV- and high-HBV/HDV-prevalence countries," 2023, Journal of Hepatology

Best Publications

  • Ledipasvir and Sofosbuvir for Untreated HCV Genotype 1 Infection

    Nezam Afdhal;Stefan Zeuzem;Paul Kwo;Mario Chojkier

  • Telaprevir for retreatment of HCV infection.

    Stefan Zeuzem;Pietro Andreone;Stanislas Pol;Eric Lawitz

  • Interferons at age 50: past, current and future impact on biomedicine.

    Ernest C Borden;Ganes Sen;Gilles Uze;Robert H Silverman

  • Sofosbuvir and Velpatasvir for HCV Genotype 2 and 3 Infection

    Graham R. Foster;Nezam Afdhal;Stuart K. Roberts;Norbert Bräu

  • Chronic hepatitis C virus infection causes a significant reduction in quality of life in the absence of cirrhosis

    G. R. Foster;R. D. Goldin;H. C. Thomas

  • Addressing liver disease in the UK: A blueprint for attaining excellence in health care and reducing premature mortality from lifestyle issues of excess consumption of alcohol, obesity, and viral hepatitis

    Roger Williams;Richard Aspinall;Mark Bellis;Ginette Camps-Walsh

  • Increase in primary liver cancer in the UK, 1979-94.

    Simon D Taylor-Robinson;Graham R Foster;Shona Arora;Sally Hargreaves

  • Hepatitis C Virus Treatment for Prevention Among People Who Inject Drugs: Modeling Treatment Scale-Up in the Age of Direct-Acting Antivirals

    Natasha K. Martin;Peter Vickerman;Jason Grebely;Margaret Hellard

  • Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease.

    Daniel M. Forton;Daniel M. Forton;Howard C. Thomas;Christine A. Murphy;Joanna M. Allsop

  • Impact of direct acting antiviral therapy in patients with chronic hepatitis C and decompensated cirrhosis.

    Graham R. Foster;William L. Irving;Michelle C.M. Cheung;Alex J. Walker

  • MAIT cells are activated during human viral infections

    B van Wilgenburg;I Scherwitzl;E C Hutchinson;T Leng

  • Glecaprevir–Pibrentasvir for 8 or 12 Weeks in HCV Genotype 1 or 3 Infection

    Stefan Zeuzem;Graham R Foster;Stanley Wang;Armen Asatryan

  • Outcomes after successful direct-acting antiviral therapy for patients with chronic hepatitis C and decompensated cirrhosis

    Michelle C.M. Cheung;Alex J. Walker;Benjamin E. Hudson;Suman Verma

  • Simeprevir with pegylated interferon alfa 2a plus ribavirin in treatment-naive patients with chronic hepatitis C virus genotype 1 infection (QUEST-1): a phase 3, randomised, double-blind, placebo-controlled trial

    Ira M Jacobson;Gregory J Dore;Graham R Foster;Michael W Fried

  • Evidence for a cerebral effect of the hepatitis C virus.

    Daniel M Forton;Daniel M Forton;Joanna M Allsop;Janice Main;Graham R Foster

  • Combination of Tenofovir Disoproxil Fumarate and Peginterferon α-2a Increases Loss of Hepatitis B Surface Antigen in Patients With Chronic Hepatitis B

    Patrick Marcellin;Sang Hoon Ahn;Xiaoli Ma;Florin A. Caruntu

  • The way forward in HCV treatment — finding the right path

    Michael P. Manns;Graham R. Foster;Jürgen K. Rockstroh;Stefan Zeuzem

  • Dengue Virus Inhibits Alpha Interferon Signaling by Reducing STAT2 Expression

    Meleri Jones;Andrew Davidson;Linda Hibbert;Petra Gruenwald

  • Preserved T-Cell Function in Children and Young Adults With Immune-Tolerant Chronic Hepatitis B

    Patrick T.F. Kennedy;Elena Sandalova;Juandy Jo;Upkar Gill

  • Efficacy of 8 Weeks of Sofosbuvir, Velpatasvir, and Voxilaprevir in Patients With Chronic HCV Infection: 2 Phase 3 Randomized Trials

    Ira M. Jacobson;Ira M. Jacobson;Eric Lawitz;Edward J. Gane;Bernard E. Willems

Frequent Co-Authors

Stefan Zeuzem
Stefan Zeuzem Goethe University Frankfurt
Ira M. Jacobson
Ira M. Jacobson New York University
Zobair M. Younossi
Zobair M. Younossi Inova Health System
Stanislas Pol
Stanislas Pol Université Paris Cité
Gregory J. Dore
Gregory J. Dore University of New South Wales
Robert D. Goldin
Robert D. Goldin Imperial College London
Mark S. Sulkowski
Mark S. Sulkowski Johns Hopkins University School of Medicine
William L. Irving
William L. Irving University of Nottingham
Howard C. Thomas
Howard C. Thomas Imperial College London
Peter Ferenci
Peter Ferenci Medical University of Vienna

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring medicine in the USA doesn’t only mean becoming an MD. There’s a diverse array of professional and academic pathways you can pursue online. For example, if you want to enter the workforce quickly, fast track medical lpn programs online can prepare you for a career as a Licensed Practical Nurse in as little as one year.

If you’re already a registered nurse, consider advancing your career with bsn to np programs online. These programs offer specialized training and flexible learning formats, allowing you to become a Nurse Practitioner without pausing your current employment.

Interested in healthcare management? Affordable options exist for earning your online degree. Check out the cheapest online healthcare administration degree options to develop leadership and administrative skills. For those ready to advance further, understanding the cost of mha degree can help you plan for a master’s in healthcare administration.

Whether you’re seeking clinical or administrative roles, these online pathways offer flexibility, affordability, and the opportunity to make a real impact in healthcare.

Best Scientists Citing Graham R. Foster

Trending Scientists

Recently Published Articles